F
or immediate release
16 December
20
2
1
Serabi Gold plc
(“Serabi” or the “Company”)
Serabi Gold plc (the “Company”)
Arrangements for Extraordinary General Meeting
Further to our announcement on 25 November 2021 in relation to the Extraordinary General Meeting of the Company to be held on 22 December 2021 (the ”
EGM
“), we confirm that shareholders are still able to attend the EGM in person. However, in view of the continuing risk posed by COVID-19 and for the health and safety of our shareholders, employees and the Board, our preference remains that shareholders do not make plans to attend the EGM in person and instead appoint the Chairman of the EGM as their proxy. In line with current UK Government guidance, we have been requested, by the venue hosting the meeting, to ask that any shareholders who do still wish to attend the EGM in person take a lateral flow test on the morning of the meeting. Shareholders should not attend the EGM if they feel unwell or have been in contact with anyone who has tested positive for COVID-19. In line with UK Government Guidance, it is also requested that any shareholders attending the EGM in person wear a face covering for the duration of the meeting, unless they are exempt.
Enquiries:
Serabi Gold plc |
|
Michael Hodgson |
Tel: +44 (0)20 7246 6830 |
Chief Executive |
Mobile: +44 (0)7799 473621 |
Clive Line |
Tel: +44 (0)20 7246 6830 |
Finance Director |
Mobile: +44 (0)7710 151692 |
Email: [email protected] |
|
Website: www.serabigold.com |
|
Beaumont Cornish Limited Nominated Adviser |
|
Roland Cornish |
Tel: +44 (0)20 7628 3396 |
Michael Cornish |
Tel: +44 (0)20 7628 3396 |
Peel Hunt LLP Joint UK Broker |
|
Ross Allister |
Tel: +44 (0)20 7418 9000 |
Tamesis Partners LLP Joint UK Broker |
|
Charlie Bendon |
Tel: +44 (0)20 3882 2868 |
Richard Greenfield |
Tel: +44 (0)20 3882 2868 |
Camarco Financial PR Gordon Poole / E mily Hall |
|
Copies of this announcement are available from the Company’s website at
www.serabigold.com
.
Neither the Toronto Stock Exchange, nor any other securities regulatory authority, has approved or disapproved of the contents of this announcement.
ENDS
Attachment